Literature DB >> 16216098

Infection with Fasciola hepatica.

D Y Aksoy1, U Kerimoglu, A Oto, S Erguven, S Arslan, S Unal, F Batman, Y Bayraktar.   

Abstract

Fascioliasis, caused by the liver fluke Fasciola hepatica, is an infection that occurs worldwide, although humans are accidental hosts. F. hepatica infection comprises two stages, hepatic and biliary, with different signs and symptoms. Stool examination and ELISA can be used for the initial diagnosis. Radiographic techniques, such as computerised tomography and ultrasonography, as well as magnetic resonance imaging, are used widely for confirmation and follow-up of the disease. Invasive techniques, such as percutaneous cholangiography, endoscopic retrograde cholangiography and liver biopsy, may aid in the diagnosis but are not essential. Triclabendazole is recommended as the first-line agent for the treatment of F. hepatica infection, with bithionol as an alternative.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216098     DOI: 10.1111/j.1469-0691.2005.01254.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  15 in total

1.  Fasciola hepatica-a "Diver" in the Biliary Tree.

Authors:  Aires Martins; Álvaro Gonçalves; Teresa Almeida; Luís Lopes; Alberto Midões
Journal:  J Gastrointest Surg       Date:  2017-06-20       Impact factor: 3.452

2.  Biliary parasites: diagnostic and therapeutic strategies.

Authors:  Niraj Khandelwal; Joanna Shaw; Mamta K Jain
Journal:  Curr Treat Options Gastroenterol       Date:  2008-04

3.  A case of probable mixed-infection with Clonorchis sinensis and Fasciola sp.: CT and parasitological findings.

Authors:  Tae Yun Kim; Yun-Sik Lee; Ji Hye Yun; Jeong Ju Kim; Won Hyung Choi; In Hwan Oh; Hyun Ouk Song; Jong Phil Chu
Journal:  Korean J Parasitol       Date:  2010-06-17       Impact factor: 1.341

Review 4.  Recent Developments in Recombinant Proteins for Diagnosis of Human Fascioliasis.

Authors:  Abolfazl Mirzadeh; Farid Jafarihaghighi; Elham Kazemirad; Shokouh Shahrokhi Sabzevar; Mohammad Hossein Tanipour; Mehdi Ardjmand
Journal:  Acta Parasitol       Date:  2020-09-24       Impact factor: 1.440

5.  An incidental case of biliary fascioliasis with subtle clinical findings: US and MRCP findings.

Authors:  Hakan Onder; Faysal Ekici; Emin Adin; Suzan Kuday; Hatice Gümüş; Aslan Bilici
Journal:  Radiol Oncol       Date:  2013-05-21       Impact factor: 2.991

6.  Cholangiocarcinoma in magnetic resonance cholangiopancreatography and fascioliasis in endoscopic ultrasonography.

Authors:  Amir Houshang Mohammad Alizadeh; Mohammad Roshani; Farhad Lahmi; Nasrin Ahangar Davoodi; Mohammad Rostami Nejad; Mohammad Reza Seyyedmajidi; Mohammad Reza Zali
Journal:  Case Rep Gastroenterol       Date:  2011-10-01

7.  A Fascioliasis Case: a not Rare Cause of Hypereosinophilia in Developing Countries, Present in Developed too.

Authors:  Ismail Necati Hakyemez; Gülali Aktaş; Haluk Savli; Abdülkadir Küçükbayrak; Safiye Gürel; Tekin Taş
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-05-08       Impact factor: 2.576

8.  Finding of biliary fascioliasis by endoscopic ultrasonography in a patient with eosinophilic liver abscess.

Authors:  Catherine Behzad; Farhad Lahmi; Majid Iranshahi; Amir Houshang Mohammad Alizadeh
Journal:  Case Rep Gastroenterol       Date:  2014-10-08

9.  Seroprevalence of Human Fascioliasis in Chaharmahal and Bakhtiyari Province, Southwestern Iran.

Authors:  Kouroush Manouchehri Naeini; Farnaz Mohammad Nasiri; Mohammad Bagher Rokni; Soleiman Kheiri
Journal:  Iran J Public Health       Date:  2016-06       Impact factor: 1.429

Review 10.  Snail-borne parasitic diseases: an update on global epidemiological distribution, transmission interruption and control methods.

Authors:  Xiao-Ting Lu; Qiu-Yun Gu; Yanin Limpanont; Lan-Gui Song; Zhong-Dao Wu; Kamolnetr Okanurak; Zhi-Yue Lv
Journal:  Infect Dis Poverty       Date:  2018-04-09       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.